These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8304980)

  • 21. Glabrol, an acyl-coenzyme A: cholesterol acyltransferase inhibitor from licorice roots.
    Choi JH; Rho MC; Lee SW; Kwon OE; Park HR; Kang JY; Lee SH; Lee HS; Bae KH; Kim YK
    J Ethnopharmacol; 2007 Apr; 110(3):563-6. PubMed ID: 17123760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
    Christensen JG; LeBlanc GA
    Cancer Res; 1996 Feb; 56(3):574-81. PubMed ID: 8564974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsomal long chain fatty acyl-CoA transacylation: differential effect of sterol carrier protein-2.
    Chao H; Billheimer JT; Kier AB; Schroeder F
    Biochim Biophys Acta; 1999 Aug; 1439(3):371-83. PubMed ID: 10498408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Kitayama K; Koga T; Inaba T; Fujioka T
    Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Synthesis and hypocholesterolemic activity of dibenz[b,e]oxepin-11-carboxanilides.
    Kumazawa T; Yanase M; Harakawa H; Obase H; Shirakura S; Ohishi E; Oda S; Kubo K; Yamada K
    J Med Chem; 1994 Mar; 37(6):804-10. PubMed ID: 8145231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells.
    Rea TJ; DeMattos RB; Homan R; Newton RS; Pape ME
    Biochim Biophys Acta; 1996 Jan; 1299(1):67-74. PubMed ID: 8555254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes.
    Hernández ML; Martínez MJ; López de Heredia M; Ochoa B
    Biochim Biophys Acta; 1997 Nov; 1349(3):233-41. PubMed ID: 9434137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of acyl-CoA: cholesterol acyltransferase. II. Preparation and hypocholesterolemic activity of optically active dibenz[b,e]oxepin-11-carboxanilides.
    Kumazawa T; Yanase M; Shirakura S; Ohishi E; Yamada K; Matsumiya S; Kono M
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):222-5. PubMed ID: 8582041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,3,22,23-tetrahydroxyl-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetraene, an acyclic triterpenoid isolated from the seeds of Alpinia katsumadai, Inhibits acyl-CoA : cholesterol acyltransferase activity.
    Choi SY; Lee MH; Choi JH; Kim YK
    Biol Pharm Bull; 2012; 35(11):2092-6. PubMed ID: 23123480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of exogenous cholesterol in diabetic rats: effects of treatment with insulin or with an acyl-CoA:cholesterol acyltransferase inhibitor.
    Maechler P; Wollheim CB; Bentzen CL; Niesor E
    Ann Nutr Metab; 1993; 37(4):199-209. PubMed ID: 8215237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential blood lipid-lowering effects of alkylsulfonated chitosan of different molecular weights in Syrian hamsters in vivo.
    Wu CC; Lin SY; Chen CT; Chang YP; Huang YS; Lii CK; Yu CC; Hsieh SL; Chung JG
    Mol Med Rep; 2012 Mar; 5(3):688-94. PubMed ID: 22159572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synergistic upregulation of phase II detoxification enzymes by glucosinolate breakdown products in cruciferous vegetables.
    Nho CW; Jeffery E
    Toxicol Appl Pharmacol; 2001 Jul; 174(2):146-52. PubMed ID: 11446830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of acyl-CoA:cholesterol acyltransferase inhibitor-low density lipoprotein complex on experimental atherosclerosis.
    Tauchi Y; Yoshimi A; Shirahase H; Sato J; Ito K; Morimoto K
    Biol Pharm Bull; 2003 Jan; 26(1):73-8. PubMed ID: 12520177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets.
    Lee HT; Sliskovic DR; Picard JA; Roth BD; Wierenga W; Hicks JL; Bousley RF; Hamelehle KL; Homan R; Speyer C; Stanfield RL; Krause BR
    J Med Chem; 1996 Dec; 39(26):5031-4. PubMed ID: 8978833
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel indoline-based acyl-CoA: cholesterol acyltransferase inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities.
    Shoji Y; Takahashi K; Ohta M; Kasai M; Kunishiro K; Kanda M; Yogai S; Takeuchi Y; Shirahase H
    Bioorg Med Chem; 2009 Aug; 17(16):6020-31. PubMed ID: 19608421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.